Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyne SCHEMBL1241853 | 0.93 | KDM4E (0.32) | KDM4ETSHRTDP1 | |
| SCHEMBL892007 | 0.79 | KDM4E (0.42) | KDM4ETSHRTDP1 | |
| SCHEMBL675792 | 0.76 | KDM4E (0.41) | KDM4ETSHRTDP1 | |
| SCHEMBL7785481 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL17044021 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL3964975 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL3969935 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL5971543 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL17044020 | 0.74 | TSHR (0.39) | KDM4ETSHRTDP1 | |
| SCHEMBL333613 | 0.74 | KDM4E (0.35) | KDM4ETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388962-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORP (US) | 2025-12-25 | — | — | US | claimed |
| WO-2025235739-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORPORATION (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250244419-A1 | INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) | 2025-07-31 | — | — | US | claimed |
| WO-2025119223-A1 | METHOD FOR SYNTHESIZING AMANITIN AND DERIVATIVE THEREOF | 上海皓元生物医药科技有限公司 | 2025-06-12 | — | — | WO | claimed |
| CN-119725748-A | High-fluorine lithium aluminate, preparation method and application thereof, electrolyte and application thereof, and lithium battery | 昆山杜克大学 | 2025-03-28 | — | — | CN | claimed |
| EP-4504404-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4505201-A1 | INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-02-12 | — | — | EP | claimed |
| CN-119300914-A | SABRE catalysts containing fluorinated carbon chains for delivery of metal-free MRI contrast agents | 美国卫生和人力服务部 | 2025-01-10 | — | — | CN | claimed |
| CN-119213327-A | Infusion device for preparing and delivering MRI probes | 美国卫生和人力服务部 | 2024-12-27 | — | — | CN | claimed |
| CN-118598774-B | Cyanoethyl ether compound and preparation method and application thereof | 上海如鲲新材料股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-6309042-B1 | Marking materials and marking processes therewith | XEROX CORPORATION | 2001-10-30 | — | — | US | claimed |
| EP-1030896-A1 | PROCESS FOR JOINING MICROSTRUCTURED PLASTIC PARTS AND COMPONENT PRODUCED BY THIS PROCESS | INSTITUT FÜR MIKROTECHNIK MAINZ GmbH (DE) | 2000-08-30 | — | — | EP | claimed |
| WO-1999025783-A1 | PROCESS FOR JOINING MICROSTRUCTURED PLASTIC PARTS AND COMPONENT PRODUCED BY THIS PROCESS | INSTITUT FüR MIKROTECHNIK MAINZ GMBH (DE) | 1999-05-27 | — | — | WO | claimed |
| US-5728336-A | High-strength, high-modulus, compound-filament or compound-film implant and method for producing it | SYNTHES (U.S.A.) (US) | 1998-03-17 | — | — | US | claimed |
| US-5453321-A | High molecular weight polyesters from naphthalenedicarboxylic acid, 4,4*-dibenzoic acid and ethylene glycol for biaxial oriented films and fibers | HOECHST CELANESE CORP. (US) | 1995-09-26 | — | — | US | claimed |
| EP-0499917-B1 | High-strength, high-modulus, compound-filament or compound-film implant and method for producing it | SYNTHES AG (CH) | 1994-08-24 | — | — | EP | claimed |
| EP-0499917-A1 | High-strength, high-modulus, compound-filament or compound-film implant and method for producing it | Synthes AG, Chur (CH) | 1992-08-26 | — | — | EP | claimed |
| US-4115989-A | Product and process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250244419-A1 | INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES | MPI, HAMP, HIF1A | KDM4E 4155/4885TSHR 1785/4885TDP1 4284/4885 |
| US-20250388962-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | RNGTT, METTL16, RNASEL | KDM4E 377/4885TSHR 4078/4885TDP1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.